Evidence capacity for niche challengers
Compete above
your headcount.
Your niche is too specific for the analyst firms and too small to staff a research team. Tensorust finds the exact public record your question lives in, connects it, and hands you the answer your larger competitor pays a department to produce.
Not another AI assistant◆ Not a database subscription◆ An outsourced evidence department
Your competitors have more analysts. They should not know more than you.
$266M announced
$22M
The announced ceiling and the money actually obligated are different fields in the same federal record. One lookup separates them.
✓ Every finding links to its original record ✓ Public and permitted sources only ✓ Limits stated, never overclaimed ✓ Free sample before you commit
The fight you are actually in
The company across from you is not smarter. It is staffed.
A larger competitor runs functions you cannot afford to hire: a market intelligence desk, regulatory affairs, a capture team, a research group. That is the real gap. Not talent, not technology. Capacity to find and reconcile evidence.
The incumbent across from you
- A market intelligence function tracking your category full time
- Regulatory affairs staff who read every rulemaking and standard
- A capture team watching contract vehicles and recompetes
- Analysts who assemble the diligence packet before the meeting
You
- Experts who are already fully committed to the product
- No one whose job is to watch the record
- Days lost every time a real question comes up
- The same public evidence available to you, and no time to reach it
Tensorust connects contracts, filings, grants, patents, research, regulation and corporate records into cited intelligence that smaller teams can act on immediately.
Your experts make the judgment. Tensorust eliminates the days spent finding and reconciling the evidence.
What we build
Not a how-to. The answer itself, in a form you can put in front of a buyer, a board, an agency or an investor.
Each one is a defined deliverable built from primary records, with every figure linked back to the source and the coverage limits written in.
01
Incumbent Weakness Map
Where the larger competitor is actually exposed. Contracts approaching recompete, thin or expiring patent coverage, recalls and safety findings, published security exposure, lapsed registrations, quiet retreats from a segment. Every exposure tied to the record that shows it.
Bought by founders and commercial leads who need to know where to push.
02
Market Entry Evidence Pack
What the market actually looks like before you commit to it. Who holds the contracts, which agencies and buyers are active, what the standards require, who the incumbents are, and where public money is already moving.
Bought by strategy and US expansion leads.
03
Contract Opportunity Map
Federal and institutional buying activity in your category. Who won, how much was actually obligated against the announced ceiling, when the recompete lands, and which offices buy the thing you make.
Bought by business development and capture leads.
04
Regulatory Window Monitor
The standards, rulemaking, agency programs and funding lines that open or close a window for your technology, tracked continuously, so a change reaches you while you can still act on it.
Bought by policy leads and regulated-market operators.
05
Competitor Claim Audit
Test what a competitor says in public against what the record shows. Announced contract value against dollars actually obligated. Claimed approvals against the regulatory record. Claimed scale against filings. Supported, overstated, or missing context, with the evidence attached.
Bought by product marketing and commercial teams.
06
Investor Diligence Packet
Institutional-quality diligence on a company or a sector without an institutional research operation. Assembled from primary records, with the limits stated plainly so a partner can rely on it in an investment committee.
Bought by partners and principals at smaller funds.
07
Technical Credibility Pack
The cited evidence a conservative buyer needs before adopting something new: the research base behind the technology, federal validation and funding, standards position, and comparable public deployments. Built to be handed directly to a skeptical customer.
Bought by industrial and advanced-material companies selling into cautious markets.
08
Monthly Competitive Evidence Monitor
The department that keeps running. Funding, standards, policy, contract and competitor changes in your category, delivered on a cadence, so nobody on your team loses days searching for something that moved last week.
Bought by teams who need the advantage to compound, not expire.
Who it is for
Not an industry. A specific desk, in a specific niche, that needs a specific record.
We do not sell to "manufacturers" or "biotech." We sell to the person below, who needs one particular slice of the public record and does not have a research team to assemble it. If this is your exact seat, we already know the datasets your answer lives in.
The pattern. Usually between 5 and 200 employees, in a niche narrow enough that no analyst firm covers it properly. Selling into a market that is regulated, procurement-driven, standards-bound, or technically conservative. Facing a competitor with many times the staff. The record that answers your question is already public and specific to your niche. We show you that record. Reaching it is the problem Tensorust solves.
What a finding looks like
One number you can act on, and the records that make it defensible.
These come from live public records. The data was already public. The advantage comes from joining the right records and knowing what the fields actually mean.
Competitor claim audit
$266M→$22M
announced headline to dollars actually obligated, on the record
A competitor's biggest number, checked in one lookup.
The announced ceiling and the money actually obligated are different fields. We pull both and link the award.
Incumbent exposure
94,000→1,647
reported vulnerabilities to the ones CISA lists as actively exploited
The exposure that is real, separated from the noise.
Severity tells you what could hurt. Exploitation tells you what attackers already use. One field turns a wall of findings into a short list.
Answer vs evidence
$18.1M→122
one usable answer, and the 122 original federal filings behind it
Every amount itemized. Every filing linked.
The total moves the conversation. The source trail is what survives the pushback.
Free tools
Check the work before you spend anything.
See the work
Real source-linked packets. Open any one and inspect the citations.
These were not written as reports. Each is a prototype of an outsourced evidence department: the days of first-pass work a larger competitor's staff would have done internally, already assembled and cited.
Featured: Competitor Claim Audit
Wind-Blade Recycling Evidence Audit
Twenty common absolute claims in composites recycling, tested against cited Crossref and U.S. DOE records, with a transparent decision and stated limits for each claim. The kind of packet that ends an argument with a conservative buyer.
20 claimsDOE + CrossrefClaim-by-claim
Advanced Materials
Graphene / 2D Materials Landscape
A cited snapshot of where the field is actually active, which institutions lead it, and which work merits deeper review before a technical bet.
Topic trendsLeading institutionsSource linked
Battery & Energy
Solid-State Battery Materials
A cited public-record landscape for locating research momentum, visible institutions, technical themes, and the papers worth opening first.
Research momentumInstitution scanCited papers
Investor Diligence
Geographic Atrophy Diligence Brief
A four-page decision packet that turns a broad question into an auditable starting point: activity, leaders, institutions, topics, and direct source links.
4 pagesCurrent recordsDirect citations
Investor Diligence
CRISPR-Enabled CAR-T Cell Therapy
A research-leadership and momentum packet for scoping an emerging platform area without treating publication volume as a commercial conclusion.
600 records4 pagesSource-limited
Life Sciences
Allogeneic iPSC Cell Therapy
A cited sample showing the research and institution signals a small team can use to frame deeper diligence on a platform bet.
270 records4 pagesCitations
Each packet is a starting point for a defined competitive question, not a claim of exhaustive coverage or a substitute for your own domain judgment. We build these for any market, technology, competitor set, or region.
Pricing
Project-based, priced against the analyst you cannot afford to hire.
Every engagement starts with a free cited sample so you can check the evidence before you commit. Prices are starting points. The scope, meaning depth, sources, competitor set and cadence, sets the quote.
Start here: free
Evidence Sample
$0
One decision, one page, fully cited. We do the first-pass public-record work for a live question your team is facing right now.
Single audit
Competitor Claim Audit
$299
One competitor, one set of public claims, tested against the record. Supported, overstated, or missing context, with every figure linked.
Most popular
Evidence Pack
$1,500
A full scoped deliverable, about one to two weeks:
- Incumbent Weakness Map
- Market Entry Evidence Pack
- Contract Opportunity Map
- Technical Credibility Pack
Major decision
Investor Diligence Packet
from $5,000
Multi-source diligence on a company or sector for a major decision. Custom scope, quoted to the work, built to hold up in an investment committee.
Ongoing
Monthly Competitive Evidence Monitor
$600/month
Continuous coverage of funding, standards, policy, contracts and competitor movement in your category. Includes the Regulatory Window Monitor. Available after a first engagement.
The headcount math
Pay for the evidence, not the headcount.
The five-hour figure is a simple staffing illustration, not a consultant quote or a claim that every manual assignment takes five hours. NIH's life-sciences guide lists $100 to $200 per hour for foundational data collection and research support, and $200 to $400 for mid-level consultants. A separate medical-communications guide lists medical-strategy contractors at $130 to $160 per hour. These are life-sciences benchmarks; rates in other sectors vary by scope, seniority and geography. NIH SEED rate guide · EPM Scientific medical-communications guide
Life-sciences teams can also buy a self-serve cited research-leader brief for $149, delivered automatically. Need something else? Ask for a custom quote.
Free evidence sample
Give us one competitive question and we will do the first-pass work for it, free.
Tell us the fight you are in. We will send back a one-page cited packet built from primary records, so you can judge the evidence before you spend anything.
Method & trust
Why you can put it in front of a buyer, a board, or an agency.
- Primary records only. Federal contracts and awards, corporate filings, lobbying disclosures, grants, patents, regulatory and safety records, and the scholarly literature, with rights and provenance retained on every record.
- Traceable claims. Every figure links to the record it came from, so the person you hand it to can verify instead of trust.
- Stated limits. Coverage, sampling and entity-matching caveats are written into every deliverable. A finding we cannot support is reported as unsupported.
- No fabrication. We never invent demand, contacts, competitors, or results.
- Judgment stays with you. Tensorust does not replace domain expertise, legal review, or technical diligence. It removes the days spent assembling the evidence those judgments rest on.
Federal contractsSEC filingsLobbying disclosuresFederal grantsPatentsStandards & rulemakingSafety & recallsVulnerability recordsScholarly literature
Life sciences
Emerging biotech, medtech and pharma teams have a running start here.
Tensorust already carries cited research-leader maps across 59 therapeutic areas and a live preview you can run right now. Enter a topic and get research leaders, institutions and active subtopics in seconds.
Built by Matthew Busel
Founder and engineer. I built the evidence engine and every tool on this site, in public. When you hire Tensorust you are not buying a seat in a platform. You are getting a real person who will go find the record, and every number traces to a source you can open yourself.
Contact
Tell us who you are competing against.
Send the market, the competitor, or the decision in front of you. We will send back a short cited sample and scope what your team would spend in hours to assemble it by hand.
Or write directly: mattbusel@gmail.com
Your data stays yours. Tensorust reads only public government, corporate and scholarly records. We store no private data, and nothing you tell us about your market is sold, shared, or used to train anything.